Pacira BioSciences, Inc. (PCRX) insider trading

By person

16 insiders · 17 transactions

26.7×

Frank Lee holds 26.7 times base salary in stock. $24.00M of shares against $896.54K in salary for 2024.

Salary from the company's own proxy. The shares are what Frank Lee last reported holding, valued at $36.32, the price Common Stock was last bought or sold at on the open market here, on 8 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Shawn Cross

Chief Financial Officer

—

$1.52M (7) scheduled

−$1.52M

95,801

0.2403%

$3.48M

+27.7%

Kristen Williams

Chief Administrative Officer

—

$498.17K (2) scheduled

−$498.17K

167,062

0.4191%

$6.07M

+62.3%

Lauren Riker

Senior Vice President, Finance

—

$479.19K (4) scheduled

−$479.19K

62,284

0.1563%

$2.26M

+59.1%

Jonathan Slonin

Chief Medical Officer

—

$240.43K (3) scheduled

−$240.43K

216,384

0.5428%

$7.86M

+124.4%

Mark Froimson

Director

—

$10.91K (1)

−$10.91K

26,541

0.0666%

$963.97K

+83.4%

Frank D. Lee

Chief Executive Officer

—

660,831

1.66%

$24.00M

+505.4%

Daryl Gaugler

Chief Operating Officer

—

115,443

0.2896%

$4.19M

−0.2%

Brendan Teehan

Chief Commercial Officer

—

100,934

0.2532%

$3.67M

—

Mark A. Kronenfeld

Director

—

34,901

0.0876%

$1.27M

+40.2%

Laura Brege

Director

—

30,120

0.0756%

$1.09M

+71.6%

Christopher Christie

Director

—

23,059

0.0578%

$837.50K

+119.8%

Michael J. Yang

Director

—

19,798

0.0497%

$719.06K

+173.8%

Alethia Young

Director

—

17,798

0.0446%

$646.42K

+240.3%

Marcelo Bigal

Director

—

17,798

0.0446%

$646.42K

+75.5%

Abraham Ceesay

Director

—

9,039

0.0227%

$328.30K

+72.8%

Samit Hirawat

Director

—

6,405

0.0161%

$232.63K

—

Pacira BioSciences, Inc.

What the insiders did Mostly scheduled

By person